Search Results for "Human Trafficking"
Displaying 1 - 20 of 25 results. 20 results shown per page. Page 1 of 2.
Inflation Reduction Act Research Series: Understanding Development and Trends in Utilization and Spending for Drugs Selected Under the Medicare Drug Price Negotiation Program
Publication Date
The Inflation Reduction Act (IRA) authorizes the Secretary of the Department of Health and Human Services (HHS) to negotiate prices directly with participating manufacturers for selected drugs that are high expenditure, single source drugs without generic or biosimilar competition.
The Inflation Reduction Act of 2022: One Year Anniversary Highlights from ASPE Drug Pricing Reports
Publication Date
Introduction
Medicare Part B Drugs: Trends in Spending and Utilization, 2008-2021
Publication Date
The U.S. Department of Health and Human Services (HHS), Office of the Assistant Secretary for Planning and Evaluation (ASPE) released new research on spending and utilization trends of Medicare Part B drugs, drugs administered in physicians' office or hospital outpatient departments rather than being purchased at the pharmacy counter or by mail order.
Report to Congress: Prescription Drug Pricing Report
Publication Date
The Secretary of Health and Human Services (HHS) has been directed to submit a drug pricing report containing information requested by the House Committee on Appropriations.
Competition and Choice in the Health Insurance Marketplaces, 2014-2015: Impact on Premiums
Publication Date
ASPE ISSUE BRIEF Steven Sheingold, Nguyen Nguyen, and Andre Chappel Disclaimer Persons with disabilities having problems accessing this document may call (202) 690-6870 for assistance.
State Purchasing Strategies Drive State Contracts with Medicare Special Needs Plans
Publication Date
U.S. Department of Health and Human Services
Medicaid Contracts with Medicare Special Needs Plans Reflect Diverse State Approaches to Dually Eligible Beneficiaries
Publication Date
U.S. Department of Health and Human Services
Federal Authority for Medicare Special Needs Plans and their Relationship to State Medicaid Programs
Publication Date
U.S. Department of Health and Human Services
Prescription Drug Spending by Medicare Beneficiaries in Institutional and Residential Settings, 1998-2001
Publication Date
U.S. Department of Health and Human Services
Why Different Purchasers Pay Different Prices for Prescription Drugs
Publication Date
by Anna Cook, Ph.D. Mathematica Policy Research, Inc. A memorandum prepared for the Department of Health and Human Services Conference on Pharmaceutical Pricing Practices, Utilization and Costs August 8-9, 2000
The Graying of Medicare's Disabled Population: Implication for a Medicare Drug Benefit
Publication Date
U.S. Department of Health and Human Services
Pricing Mechanisms Used by the Federal Government to Contain Prescription Drug Costs
Publication Date
by Anna Cook, Ph.D. Mathematica Policy Research, Inc. A memorandum prepared for the Department of Health and Human Services’ Conference on Pharmaceutical Pricing Practices, Utilization and Costs August 8-9, 2000
Cost Control for Prescription Drug Programs: Pharmacy Benefit Manager (PBM) Efforts, Effects, and Implications
Publication Date
by David H. Kreling, Ph.D., R.Ph. Sonderegger Research Center University of Wisconsin School of Pharmacy A background report prepared for the Department of Health and Human Services' Conference on Pharmaceutical Pricing Practices, Utilization and Costs
The Graying of Medicare's Disabled Population: Implication for a Medicare Drug Benefit
Publication Date
U.S. Department of Health and Human Services The Graying of Medicares Disabled Population: Implication for a Medicare Drug Benefit
Prescription Drug Spending by Medicare Beneficiaries in Institutional and Residential Settings, 1998-2001
Publication Date
U.S. Department of Health and Human Services
Drug Use and Spending for Medicare Beneficiaries During Part A Qualifying Skilled Nursing Facility Stays and Non-Qualifying Long-Term Care Facility Stays
Publication Date
U.S. Department of Health and Human Services
Securing the Benefits of Medical Innovation for Seniors: The Role of Prescription Drugs and Drug Coverage
Publication Date
EXECUTIVE SUMMARY Americans are living longer and healthier lives. By the year 2030, the number of Americans over the age of 65 is projected to double to 70 million. The life expectancy of the average American is increasing, and the rates of mortality, morbidity, and disability among Americans over age 65 have steadily decreased.
Payment for Medicare Advantage Plans: Policy Issues and Options
Publication Date
PAYMENT FOR MEDICARE ADVANTAGE PLANS: POLICY ISSUES AND OPTIONS
Office of Health PolicyOffice of the Assistant Secretary for Planning & Evaluation U.S. Department of Health & Human Services
Cost Control for Prescription Drug Programs: Pharmacy Benefit Manager (PBM) Efforts, Effects, and Implications
Publication Date
by David H. Kreling, Ph.D., R.Ph. Sonderegger Research Center University of Wisconsin School of Pharmacy A background report prepared for the Department of Health and Human Services' Conference on Pharmaceutical Pricing Practices, Utilization and Costs August 8-9, 2000 Leavey Conference Center, Georgetown University